MedCap AB (Sweden) Today
| MCAP Stock | SEK 569.00 6.00 1.07% |
Performance3 of 100
| Odds Of DistressLess than 9
|
MedCap AB is selling for under 569.00 as of the 26th of November 2024; that is 1.07% up since the beginning of the trading day. The stock's last reported lowest price was 559.0. MedCap AB has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for MedCap AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of January 2023 and ending today, the 26th of November 2024. Click here to learn more.
MedCap AB is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. MedCap AB was founded in 2001 and is based in Stockholm, Sweden. MedCap AB operates under Medical Equipment classification in Sweden and is traded on Stockholm Stock Exchange.. The company has 14.81 M outstanding shares. More on MedCap AB
Moving against MedCap Stock
MedCap AB cannot be verified against its exchange. Apparently, MedCap AB is not available for investing at the moment. Please verify the symbol is currently traded on Stockholm Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshMedCap Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. MedCap AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding MedCap AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Asset Management, Financial Services (View all Sectors) |
MedCap AB (MCAP) is traded on Stockholm Exchange in Sweden and employs 3 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.57 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MedCap AB's market, we take the total number of its shares issued and multiply it by MedCap AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. MedCap AB operates under Financial Services sector and is part of Asset Management industry. The entity has 14.81 M outstanding shares.
MedCap AB has accumulated about 139.7 M in cash with 116.3 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.17.
Check MedCap AB Probability Of Bankruptcy
MedCap AB Risk Profiles
Although MedCap AB's alpha and beta are two of the key measurements used to evaluate MedCap AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.0 | |||
| Semi Deviation | 2.21 | |||
| Standard Deviation | 2.48 | |||
| Variance | 6.16 |
MedCap Stock Against Markets
Try Other Suggestions
Be your own money manager
Our tools can tell you how much better you can do entering a position in MedCap AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Additional Tools for MedCap Stock Analysis
When running MedCap AB's price analysis, check to measure MedCap AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedCap AB is operating at the current time. Most of MedCap AB's value examination focuses on studying past and present price action to predict the probability of MedCap AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedCap AB's price. Additionally, you may evaluate how the addition of MedCap AB to your portfolios can decrease your overall portfolio volatility.